HAPILA and Transo-Pharm together at CPHI Frankfurt 2022 - booth 110D20
HAPILA GmbH and Transo-Pharm Handels-GmbH are determined to deepen their relationship and have therefore jointly decided to expand the production capacities at the HAPILA site in Gera, mainly to meet the increasing demand for the active ingredient Estriol Micronized.